Ergotamine relieves migraine by:
A. Blocking vascular α adrenergic receptors
B. Blocking vascular 5-HT2 receptors
C. Dilating cranial arterio-venous shunt channels
D. Constricting cranial vessels and reducing perivascular neurogenic inflammation
